Clinical boundary Schedule I in the U.S. Serious cardiac risk Not FDA-approved No dosing or referrals

Claim extract · Listening Library

Facts & Fallacies: examining politicized PTSD–ibogaine claims

LAST REVIEWED 2026-09-22 · SKEPTICAL / POLICY MEDIA · MEDIUM CONFIDENCE LL

Genetic Literacy Project’s Facts & Fallacies write-up examines RFK Jr.–adjacent PTSD/ibogaine claims. Use it as claim-check media; still require primary literature for any efficacy statement.

Claim-check mediaPTSD evidence limitedNo miracle voice

Listening Library sources (outbound)

Testable claims extracted (media → primary)

  1. Claim (political / media): Ibogaine is an established PTSD treatment ready for broad use.
    Evidence desk: PTSD evidence — limited observational / secondary signals; not proven as PTSD standard care.
  2. Claim (veteran study stream): Nature Medicine magnesium–ibogaine work proves PTSD cure.
    Primary: Cherian et al. PMID 38182784 (open-label TBI-focused cohort with secondary symptom domains) + critique PMID 42330793.
  3. Claim (approval): Political endorsement equals FDA approval of ibogaine for PTSD.
    Verdict: False — FDA check + Schedule I FAQ.

Verdict

Valuable skeptical/policy media for overclaim detection; still not a primary trial. Keep PTSD and TBI pages on observational limits and refuse miracle language.

Continue reading